CLINICAL_TRIALS ClinicalTrials.gov record update

SCH 465981: Assessment of Bi-Directional Interaction Between Components of Vytorin® (Ezetimibe and Simvastatin) and Niaspan® (Niacin Extended-Release Tablets) in Healthy Subjects

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00652431
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:47.851883+00:00
Published At: 2022-02-16T00:00:00+00:00
Record Updated At: 2022-02-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hypercholesterolemia", "Hyperlipidemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-02-16"
protocolSection.identificationModule.nctId: "NCT00652431"
protocolSection.identificationModule.officialTitle: "SCH 465981: Assessment of Bi-Directional Interaction Between Components of Vytorin\u00ae (Ezetimibe and Simvastatin) and Niaspan\u00ae (Niacin Extended-Release Tablets) in Healthy Subjects"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.